Get started
AVAX TECHNOLOGIES INCAVAX TECHNOLOGIES INCAVAX TECHNOLOGIES INC

AVAX TECHNOLOGIES INC

No trades
See on Supercharts
OverviewFinancialsMindsTechnicalsSeasonals

Fundamentals and stats

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

AVAX Technologies, Inc. is an immuno-oncology company, which engages in the provision of development and commercialization of vaccine therapies and technologies for the treatment of cancer. It offers biological manufacturing services to biotechnology and pharmaceutical companies. The company was founded by Kenneth E. Kovan on January 12, 1990 and is headquartered in Philadelphia, PA.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
AVXT has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company